Bo Feng

9.3k citations
153 papers · 6.5k indexed · 1 hit paper · h-index 37
Topics
Pluripotent Stem Cells Research (25 papers)CRISPR and Genetic Engineering (24 papers)Renal and related cancers (10 papers)

In The Last Decade

Bo Feng

148 papers receiving 6.4k citations

Hit Papers

The endoplasmic reticulum is the site of cholesterol-indu...20032026201020182003200400600

Peers

Bo Feng
Comparison fields: 5 of 150
  • Molecular Biology 4.0k
  • Surgery 733
  • Genetics 715
  • Cell Biology 664
  • Cellular and Molecular Neuroscience 646
Replace Rong Zeng with:
Rong Zeng China
Yuji Arai Japan
Hui Zhao China
Hiroyoshi Ariga Japan
Etienne Waelkens Belgium
Bernd Timmermann Germany
Jun‐Yuan Ji China
Frank Schwede Germany
Jun Zhang China
Bo Feng relative to Rong Zeng China Rong Zeng's profile →
Citations per field
00.5×1.5×2.1×
Rong Zeng · 1×
Citations per year

Countries citing papers authored by Bo Feng

Since Specialization
Citations

This map shows the geographic impact of Bo Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Feng more than expected).

Fields of papers citing papers by Bo Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Feng. The network helps show where Bo Feng may publish in the future.

Co-authorship network of co-authors of Bo Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Feng. A scholar is included among the top collaborators of Bo Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Feng. Bo Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 7
5 3
6 0
7 12
8 5
9 29
10 20
11 3
12 22
13 27
14
Reform and Openness of the Chinese Economy: Effects on Regional Convergence. (Beta and Sigma Convergence, 2000-2010)
2
15 15
16 26
17 281
18 9
19 286
20 14

About Bo Feng

Bo Feng is a scholar working on Molecular Biology, Aging and Cellular and Molecular Neuroscience, having authored 153 papers that have together received 6.5k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (25 papers), CRISPR and Genetic Engineering (24 papers) and Renal and related cancers (10 papers). The work is most often cited by research in Molecular Biology (4.0k citations), Reproductive Medicine (461 citations) and Aging (83 citations). Bo Feng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Huck‐Hui Ng, Ira Tabas, George A. Marzluf, Jia-Hui Ng, Jian-Chien Dominic Heng, David B. Seifer, Benjamin P. Christian, Robert M. Shelden, David T. MacLaughlin and Dajun Zhang. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026